Efficacy and Safety of Lenvatinib Combined with Anti-Pd-1 Antibodies Plus GEMOX Chemotherapy As Non-First-line Systemic Therapy in Advanced Gallbladder Cancer
CANCER IMMUNOLOGY IMMUNOTHERAPY(2024)
Key words
Gallbladder cancer,Lenvatinib,PD-1,GEMOX,Chemotherapy,Systemic therapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined